Triclabendazole Micronized

Manufacturer: AX Pharmaceutical Corp | Alivira Animal Health LImited
Effective date: 2022-09-15
Label type: BULK INGREDIENT - ANIMAL DRUG
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:50:32

Label at a glance#

ProductTriclabendazole Micronized

Active ingredientTRICLABENDAZOLE

Label structure1 sections

Label contents#

Full prescribing information#

Triclabendazole Micronized

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
e10b03a1-8e45-4bc3-9626-8b78c34f131b	Product name	1	20190612

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73377-190-01	Triclabendazole Micronized	500 g in 1 JAR	POWDER	500		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73377-190	TRICLABENDAZOLE MICRONIZED POWDER [AX PHARMACEUTICAL CORP]	1	1 package rows	20220919_2ebc302e-1ffd-4be4-95e6-a341251c9e06.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

Triclabendazole Micronized
TRICLABENDAZOLE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
73377-190	73377-190-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TRICLABENDAZOLE	4784C8E03O	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
EGATEN	TRICLABENDAZOLE	Novartis Pharmaceuticals Corporation	5552884e-10ea-450c-9658-d3d4f33c946e	2026-06-04	Warnings, Adverse reactions	Name fallback generic name: TRICLABENDAZOLE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.